Neural stimulation and optical monitoring systems and methods

• US 7,729,773 B2
• Filed: 10/18/2006
• Issued: 06/01/2010
• Est. Priority Date: 10/19/2005
• Status: Expired due to Fees

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories)
• Inventors: Sloan, Leif R.
• Primary Examiner(s): Getzow; Scott M
• Application Number:
  US11/583,349
• Publication Number:
  US 20070100398A1
• Time in Patent Office: 1,322 Days
• Field of Search: 600300-372, 607 1- 76
• US Class Current: 607/45
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease

Abstract

Neural stimulation and optical monitoring systems and methods are disclosed. In one embodiment, an apparatus for treating a neural condition includes a signal delivery device configured to be implanted into a patient proximate to a skull of the patient and positioned to apply electromagnetic signals to one or more target sites within the patient. The apparatus also includes an implantable optical monitoring assembly configured to monitor optical properties at one or more optical monitoring sites within the patient. The apparatus further includes a controller configured to be implanted into the patient. The controller is operatively coupled to the signal delivery device and the optical monitoring assembly and programmed to control both the signal delivery device and the optical monitoring assembly. The controller also includes a power source to power both the signal delivery device and the optical monitoring assembly.

Claims

1. An apparatus for treating a neural condition, comprising:

a signal delivery device configured to be implanted into a patient proximate to a skull of the patient and positioned to apply electromagnetic signals to one or more target neural sites within the patient;

an implantable optical monitoring assembly configured to monitor optical properties at one or more optical monitoring sites within the patient, wherein the signal delivery device and optical monitoring assembly are both carried by an implantable, generally planar support member;

a controller configured to be implanted into the patient, the controller being operatively coupled to the signal delivery device and the optical monitoring assembly and programmed to control both the signal delivery device and the optical monitoring assembly, and wherein the controller includes a power source to power both the signal delivery device and the optical monitoring assembly;

the optical monitoring assembly including one or more optical emission elements carried by the support member, and one or more optical detection elements carried by the support member, wherein the one or more optical emission elements and the one or more optical detection elements are arranged relative to each other to detect optical signals from the one or more optical monitoring sites; and

wherein the one or more optical detection elements and the one or more optical emission elements are separated from each other by approximately 0.5 cm to approximately 5.0 cm and further wherein the one or more optical detection elements are arranged in a phased optical array.

2. An apparatus for treating a neural condition, comprising:

a substance delivery device configured to release or apply one or more chemical substances to one or more corresponding target sites upon or within a patient;

an implantable optical monitoring assembly configured to monitor optical properties at one or more optical monitoring sites within or proximate to the skull of the patient, wherein the optical monitoring assembly is carried by an implantable, generally planar support member, and further wherein the optical monitoring assembly includes a plurality of optical emission elements arranged in a phased optical array; and

a controller configured to be implanted into the patient, the controller being operatively coupled to the substance delivery device and the optical monitoring assembly and programmed to control both the substance delivery device and the optical monitoring assembly.

3. A method for treating a patient, comprising:

affecting a target neural population of a patient by providing to the patient one or more chemical substances;

detecting at least one optical signal in tissue at or proximate to one or more brain regions of the patient after providing the one or more chemical substances, wherein the optical signal is detected with an optical monitoring assembly carried by an implantable, generally planar support member, and further wherein the optical monitoring assembly includes a plurality of optical emission elements arranged in a phased optical array; and

based on the detected optical signal, controlling at least one substance delivery parameter in accordance with which the one or more chemical substances are provided.